Systemic lupus erythematosus ... treatments rely on clinical experience. This Review covers recent clinical advances in this area and emphasizes the need for further research.

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

The trial met its primary composite endpoint demonstrating significant clinical improvement ... in patients with moderate to severe systemic lupus erythematosus (SLE). Dapirolizumab pegol is ...

Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...

Adult patients hospitalized for aseptic or septic revision TKA were eligible for inclusion. Patients with SLE were propensity score matched in a 1:4 ratio with individuals without the disease. The ...

Phase 1 clinical trial is designed to assess the safety, pharmacokinetics and initial clinical activity of CLN-978 for patients with systemic lupus erythematosus The trial will be conducted in ...

New research suggests that higher daily intakes of ultraprocessed foods (UPFs) are associated with a higher risk of ...

Safety, pharmacokinetics and target engagement data from first-in-human Phase 1 clinical trial in healthy volunteers will potentially enable rapid advancement of IMSB301 into Phase 1b/2 clinical ...

As part of a precision medicine research collaboration ... cells (PBMCs) from systemic lupus erythematosus (SLE) patients and provided protection from clinical disease and tissue pathology in ...

Sarawak General Hospital received the award for Top Study Site in Ministry of Health for Sponsored Research in early May this year.

approval in Australia to initiate its global Phase 1 clinical trial to evaluate CLN-978, its CD19xCD3 bispecific T cell engager, for the treatment of systemic lupus erythematosus (SLE). SLE affects ...